Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library
|
March 7, 2000
The control of mitosis
M L Hixon, A Gualberto
Histology and Histopathology
|
May 16, 2000
Gain of function properties of mutant p53 proteins at the mitotic spindle cell cycle checkpoint
M L Hixon, A Flores, M Wagner, et al.
Molecular and Cellular Biology
|
October 17, 1998
Ectopic expression of cdc2/cdc28 kinase subunit Homo sapiens 1 uncouples cyclin B metabolism from the mitotic spindle cell cycle checkpoint
M L Hixon, A I Flores, M W Wagner, et al.
Laboratory Animal Science
|
December 1, 1996
Limited diversity in the major histocompatibility complex class II loci of Syrian hamster DNA
M L Hixon, A M Lewis, A S Levine, et al.
Molecular and Cellular Biology
|
June 1, 1995
A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat
A Gualberto, M L Hixon, T S Finco, et al.
The Journal of Biological Chemistry
|
September 27, 2000
Cks1 mediates vascular smooth muscle cell polyploidization
M L Hixon, C Obejero-Paz, C Muro-Cacho, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
June 8, 1999
p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression
P Ruiz-Lozano, M L Hixon, M W Wagner, et al.
Circulation
|
May 10, 2000
Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training
Y Eto, K Yonekura, M Sonoda, et al.
The Journal of Clinical Investigation
|
October 18, 2000
Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization
M L Hixon, C Muro-Cacho, M W Wagner, et al.
British Journal of Cancer
|
November 25, 2010
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
A Gualberto, M L Hixon, D D Karp, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Frontiers in Bioscience : a Journal and Virtual Library
|
March 7, 2000
The control of mitosis
M L Hixon, A Gualberto
Histology and Histopathology
|
May 16, 2000
Gain of function properties of mutant p53 proteins at the mitotic spindle cell cycle checkpoint
M L Hixon, A Flores, M Wagner, et al.
Molecular and Cellular Biology
|
October 17, 1998
Ectopic expression of cdc2/cdc28 kinase subunit Homo sapiens 1 uncouples cyclin B metabolism from the mitotic spindle cell cycle checkpoint
M L Hixon, A I Flores, M W Wagner, et al.
Laboratory Animal Science
|
December 1, 1996
Limited diversity in the major histocompatibility complex class II loci of Syrian hamster DNA
M L Hixon, A M Lewis, A S Levine, et al.
Molecular and Cellular Biology
|
June 1, 1995
A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat
A Gualberto, M L Hixon, T S Finco, et al.
The Journal of Biological Chemistry
|
September 27, 2000
Cks1 mediates vascular smooth muscle cell polyploidization
M L Hixon, C Obejero-Paz, C Muro-Cacho, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
June 8, 1999
p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression
P Ruiz-Lozano, M L Hixon, M W Wagner, et al.
Circulation
|
May 10, 2000
Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training
Y Eto, K Yonekura, M Sonoda, et al.
The Journal of Clinical Investigation
|
October 18, 2000
Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization
M L Hixon, C Muro-Cacho, M W Wagner, et al.
British Journal of Cancer
|
November 25, 2010
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
A Gualberto, M L Hixon, D D Karp, et al.
Page
of 1